RoboticsConfidence BUnited Statesactive

Entelexo Biotherapeutics

Creating a New Class of Drugs to Address Incurable Autoimmune Diseases

Official websiteentelexo.com
RegionIrvine, United States
CategoryRobotics / Embodied AI
Funding statusUnknown · Undisclosed
Last updatedJun 11, 2026
Latest signalJun 11, 2026

Status timeline

Funding, product, customer, team, and correction signals
Jun 10, 2026Confidence A
Product0 evidence links

Entelexo Biotherapeutics product scope reviewed

Entelexo Biotherapeutics public product source reviewed for category placement and current operating focus.

No source evidence matched to this event.
Jun 10, 2026Confidence B
Funding0 evidence links

Entelexo Biotherapeutics capital or status signal reviewed

Entelexo Biotherapeutics public source reviewed for capital or strategic-status timeline signal.

No source evidence matched to this event.

Funding timeline

Amounts are shown only when disclosed and tied to evidence.
Jun 10, 2026

Unknown

AmountUndisclosed
InvestorsY Combinator profile
EvidenceConfidence B
No source evidence matched to this round.

Source evidence

Public links, short factual summaries, and trust levels

Entelexo Biotherapeutics official product profile

Entelexo Biotherapeutics official site · official
Confidence A

Entelexo Biotherapeutics official source reviewed for product scope, operating focus, and category placement.

Trust APublic review
Open source

Entelexo Biotherapeutics capital or status signal

Y Combinator Startup Directory · registry
Confidence B

Entelexo Biotherapeutics public capital or strategic-status source reviewed for stage and timeline signal.

Trust BPublic review
Open source

Similar projects

Same category or overlapping tags